Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
10.1245/s10434-007-9454-0
Annals of Surgical Oncology 14:2497-2501 (2007)
© 2007 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sohn, V.
Right arrow Articles by Brown, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sohn, V.
Right arrow Articles by Brown, T.

Original Article

Atypical Ductal Hyperplasia: Improved Accuracy with the 11-Gauge Vacuum-Assisted versus the 14-Gauge Core Biopsy Needle

Vance Sohn, MD1, Zachary Arthurs, MD1, Garth Herbert, MD1, Joren Keylock, MD2, Jason Perry, MD1, Matthew Eckert, MD1, Dean Fellabaum, MD1, Donald Smith, MD3 and Tommy Brown, MD1

1 Department of Surgery, Madigan Army Medical Center, Building 9040 Fitzsimmons Drive, Tacoma, Washington, USA
2 Department of Pathology, Madigan Army Medical Center, Tacoma, Washington, USA
3 Department of Radiology, Madigan Army Medical Center, Tacoma, Washington, USA

Correspondence: Address correspondence and reprint requests to: Vance Sohn, MD; E-mail: vance.sohn{at}us.army.mil

Background: Percutaneous stereotactic core needle biopsy (CNB) has become the primary diagnostic modality for evaluating nonpalpable, mammographically detected breast lesions. Atypical ductal hyperplasia (ADH) uncovered by CNB confers a significant risk of harboring an occult malignancy in the excisional biopsy specimen; therefore, we sought to determine the benefits of upsizing biopsy needles from 14- to 11-gauge.

Methods: Patients with isolated ADH diagnosed by CNB were included for analysis in this retrospective review. Mammographic description, number of needle passes, pathology results, and follow-up data were analyzed and compared to our previously published institutional results with the 14-gauge needle.

Results: From June 1996 until July 2006, 4,579 CNBs were performed at our tertiary level medical facility. Seventy eight of 88 patients (89%) diagnosed with ADH on CNB with an 11-gauge vacuum-assisted needle underwent open surgical excision. Of these patients, nine (11%) were upgraded to ductal carcinoma in-situ (DCIS) while five (6%) had invasive cancer (IC), giving a total underestimation rate of 17%. These results differ from our previously published series of 14-gauge CNB which revealed an underestimation rate of 36%. Mean number of passes obtained at time of biopsy, mean age of patients, and characteristic radiographic abnormalities were similar for malignant and benign diagnoses.

Conclusion: 11-gauge CNB technique reduces sampling error and improves accuracy, but does not eliminate the risk of missing an underlying malignancy. Surgical excision of ADH identified by CNB is required for definitive diagnosis.

Key Words: Atypical ductal hyperplasia • Stereotactic core biopsy • Breast cancer






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society of Surgical Oncology.